Concentrix Corporation
CNXC
$44.82
$0.040.09%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.40% | 11.31% | 21.66% | 35.20% | 44.09% |
| Total Other Revenue | -- | -72.12% | -36.61% | 6.61% | 53.95% |
| Total Revenue | 3.40% | 11.31% | 21.66% | 35.20% | 44.09% |
| Cost of Revenue | 4.85% | 12.14% | 22.12% | 36.00% | 43.68% |
| Gross Profit | 0.84% | 9.84% | 20.85% | 33.78% | 44.83% |
| SG&A Expenses | -7.20% | -1.58% | 5.56% | 23.03% | 48.24% |
| Depreciation & Amortization | 51.97% | 106.96% | 221.86% | 221.86% | 175.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.23% | 12.56% | 23.74% | 38.93% | 48.51% |
| Operating Income | -6.05% | -1.77% | 1.73% | 2.45% | 7.73% |
| Income Before Tax | 43.03% | -15.13% | -9.78% | -26.69% | -46.63% |
| Income Tax Expenses | 3.99% | -39.33% | -31.62% | -49.08% | -59.54% |
| Earnings from Continuing Operations | 54.16% | -8.05% | -3.13% | -19.95% | -41.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.16% | -8.05% | -3.13% | -19.95% | -41.30% |
| EBIT | -6.05% | -1.77% | 1.73% | 2.45% | 7.73% |
| EBITDA | -5.18% | 4.70% | 16.19% | 30.04% | 42.83% |
| EPS Basic | 53.45% | -15.82% | -17.75% | -35.72% | -54.00% |
| Normalized Basic EPS | 26.60% | -12.90% | -17.24% | -31.56% | -48.27% |
| EPS Diluted | 53.55% | -15.71% | -17.57% | -35.53% | -53.83% |
| Normalized Diluted EPS | 26.67% | -12.79% | -17.06% | -31.37% | -48.07% |
| Average Basic Shares Outstanding | -1.22% | 5.14% | 12.42% | 20.76% | 25.94% |
| Average Diluted Shares Outstanding | -1.28% | 5.03% | 12.22% | 20.46% | 25.48% |
| Dividend Per Share | 10.02% | 10.01% | 10.01% | 10.00% | 10.00% |
| Payout Ratio | -0.29% | 0.25% | 0.27% | 0.65% | 1.44% |